Journal of Bone and Mineral Metabolism

, Volume 12, Supplement 1, pp S117–S119 | Cite as

Low cancer death rate in chronic dialysis patients with diabetes mellitus

  • Kunitoshi Iseki
  • Koshiro Fukiyama
Article

Abstract

Little epidemiological data is available on the association between cancer and secondary hyperparathyroidism. We previously reported that the cancer death rate is significantly higher in chronic dialysis patients who usually have secondary hyperparathyroidism than that of the general population. In diabetic dialysis watients, prevalence of secondary hyperparathyroidism was reported to be less than non-diabetic patients, consequently less renal osteodystrophy. Therefore, we further analyzed whether the diabetic dialysis patients have less cancer death rate than that of the non-diabetic patients by using the Okinawa Dialysis Registry. From the annual report on the cancer death rate in the general population, we calculated the relative risk, observed/expected ratio, in sex and age-class adjusted. The relative risk of cancer death was 4.26 in non-diabetic and 1.64 in diabetic dialysis patients. Our results support the notion that there is a close relation between parathyroid hormone and neoplasia.

Key words

cancer death rate secondary hyperparathyroidism diabetes mellitus chronic dialysis 

References

  1. 1.
    Hull AR, Parker TF III: Proceedings from the morbidity, mortality and prescription of dialysis symposium, Dallas, TX, September 15 to 17, 1989. Am J Kidney Dis 15: 375–385, 1990Google Scholar
  2. 2.
    Collins AJ, Hanson G, Umen A et al.: Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. Am J Kidney Dis 15: 422–432, 1990PubMedGoogle Scholar
  3. 3.
    Lindner A, Farewell VT, Sherrard DJ: High incidence of neoplasia in uremic patients receiving long-term dialysis. Nephron 27: 292–296, 1981PubMedGoogle Scholar
  4. 4.
    Matas AJ, Simmons RJ, Kjellstrand CM et al.: Increased incidence of malignancy during chronic renal failure. Lancet 1: 883–886, 1975PubMedGoogle Scholar
  5. 5.
    Iseki K, Kawazoe N, Osawa A et al.: Survival analysis of dialysis patients in Okinawa, Japan (1971–1990). Kidney Int 43: 404–409, 1993PubMedGoogle Scholar
  6. 6.
    Iseki K, Osawa A, Fukiyama K: Evidence for increased cancer deaths in chronic dialysis patients. Am J Kidney Dis 22: 308–313, 1993PubMedGoogle Scholar
  7. 7.
    Kopple JD, Massry SG: Is there an association between neoplasia and primary or secondary hyperparathyroidism? Am J Nephrol 8: 437–448, 1988PubMedGoogle Scholar
  8. 8.
    Vincenti F, Hattner R, Amend WJ Jr et al.: Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis. JAMA 245: 930–933, 1981CrossRefPubMedGoogle Scholar
  9. 9.
    Newbury WM, Sanford JP: Defective cellular immunity in renal failure: Depression of reactivity of lymphocytes, to phytohemagglutinin by renal failure serum. J Clin Invest 50: 1262–1271, 1971Google Scholar

Copyright information

© Japanese Society of Bone Metabolism Research 1994

Authors and Affiliations

  • Kunitoshi Iseki
    • 1
  • Koshiro Fukiyama
    • 1
  1. 1.Third Department of Internal MedicineUniversity of The RyukyusOkinawaJapan

Personalised recommendations